Independent Review of the Management of Controlled Drug Use in ...

collaborate with cross-border groups in relation to controlled drug
issues and be represented at cross-border meetings;
take regard of incidents and concerns and their outcomes to promote
best practice with respect to monitoring processes/audits of controlled
drug management, training provision and policy development.
Membership of the LIN in Northern Ireland includes, but is not limited to:
HSC Board;
HSC trusts;
Northern Ireland Ambulance Service HSC Trust;
Independent Hospitals;
Counter Fraud Unit of BSO;
DHSSPS;
RQIA;
Police Service of Northern Ireland;
Pharmaceutical Society of Northern Ireland;
Nursing and Midwifery Council;
General Medical Council;
General Dental Council;
Health and Care Professions Council.
AOs submit a quarterly Occurrence Report sharing their concerns within the
confines of the confidential LIN meeting. Organisations can learn details of
individual concerns and, wherever possible, share in the learning which has
arisen from these concerns. Designated Bodies are also encouraged to share
good practice within this forum.
6.4.2 Questionnaire Responses
Operation of the LIN
The LIN is at present chaired by DHSSPS. Members of the LIN indicated that
they were content with this arrangement. This was supported by trust senior
teams during trust validation meetings.
Responses indicated that information sent out from chair/deputy chair is well
organised and sent in a timely way. All members agreed that the chair and
deputy-chair of the LIN have a professional approach, are expert in their field,
focused on their roles and are supportive to AOs.
There is a high attendance rate at the LIN meetings.
AOs have met individually with the chair of the LIN, who has provided them
with training and support for their AO responsibilities.
Small working groups have been beneficial in building up relationships and
understanding of roles and legislation.
33